MPLT EFFECT: SEC filing
MapLight Therapeutics, Inc.
Filed with the SEC on · accession 9999999995-26-003044
MPLT filed a EFFECT (effect) with the SEC on Sep 23, 2026. A report the company filed with the SEC (the US market regulator). The stock moved -0.8% by the first close after the filing.
Summary of the filing
MapLight Therapeutics, Inc. filed an EFFECT notice with the SEC, indicating that a previously filed registration statement has become effective.
Key details
How MPLT stock reacted
Close before
$10.86
Sep 22, 2026
First close after
-0.83%
$10.77
5 trading days
-6.54%
$10.15
Since filing
-36.19%
$6.93
✦ Ask GOAX AI about this filing — what it means for MPLT, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for MPLT?
Click hereFrequently asked questions
What did MPLT file with the SEC on Sep 23, 2026?
MPLT filed a EFFECT (SEC filing). MapLight Therapeutics, Inc. filed an EFFECT notice with the SEC, indicating that a previously filed registration statement has become effective.
How do I read a EFFECT?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A EFFECT (effect): A report the company filed with the SEC (the US market regulator).
How did MPLT stock react to this filing?
MPLT closed at $10.86 before the filing and $10.77 on Sep 23, 2026 (-0.83%). Five trading days later: $10.15 (-6.54%).
Other MPLT SEC filings
- 424B3 · Secondary offeringSep 23, 2026
- S-1 · SEC filingSep 18, 2026
- S-1 · SEC filingSep 9, 2026
- SCHEDULE 13G · SEC filingAug 20, 2026
- SCHEDULE 13D/A · SEC filingAug 18, 2026
- 8-K · Secondary offeringAug 13, 2026
- 10-Q · SEC filingAug 13, 2026
- 8-K · Fda approvalJul 27, 2026
- 8-K · Board changeJun 24, 2026
- 8-K · Fda approvalJun 22, 2026
Get alerts when MPLT files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days